Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Hector A. Alvarez

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 6 November 2026

Matched on OpenAlex author ID A5104110112. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
59
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: 3 papers · 2020: none · 2021: 1 paper

Papers 9

  1. Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Co-author DOI 10.1038/s41416-021-01350-9↗
  2. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Co-author DOI 10.1038/s41467-018-08109-6↗
  3. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Last author DOI 10.1053/j.gastro.2018.09.022↗
  4. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progre… Last author DOI 10.1158/1078-0432.ccr-18-1955↗
  5. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Last author DOI 10.1093/annonc/mdx542↗
  6. Dynamic changes during the treatment of pancreatic cancer. Co-author DOI 10.18632/oncotarget.24483↗
  7. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Last author DOI 10.1093/annonc/mdx004↗
  8. 4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-17-0831↗
  9. Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep35848↗

Closest collaborators

The 25 strongest of 59 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 9 shared papers, 2016–2021 · strength 0.59
  2. Vincent Bernard · 8 shared papers, 2017–2021 · strength 0.54
  3. Matthew H. G. Katz · 7 shared papers, 2017–2021 · strength 0.49
  4. Gauri Rajani Varadhachary · 5 shared papers, 2017–2021 · strength 0.35
  5. Alexander Semaan · 3 shared papers, 2019–2021 · strength 0.25
  6. Nabiollah Kamyabi · 3 shared papers, 2019–2021 · strength 0.25
  7. Paola A. Guerrero · 3 shared papers, 2019–2021 · strength 0.25
  8. Kelvin Allenson · 4 shared papers, 2017–2019 · strength 0.24
  9. Robert A. Wolff · 3 shared papers, 2018–2019 · strength 0.19
  10. Milind M. Javle · 3 shared papers, 2017–2019 · strength 0.18
  11. Samir Hanash · 3 shared papers, 2017–2019 · strength 0.18
  12. Ignacio Ivan Wistuba · 3 shared papers, 2017–2018 · strength 0.17
  13. Jun Zhao · 2 shared papers, 2019 · strength 0.14
  14. Cullen M. Taniguchi · 2 shared papers, 2019 · strength 0.14
  15. Michela Capello · 2 shared papers, 2018–2019 · strength 0.13
  16. Jaewon James Lee · 1 shared paper, 2021 · strength 0.11
  17. Michael James Overman · 2 shared papers, 2017 · strength 0.10
  18. Patrick Hwu · 2 shared papers, 2016–2017 · strength 0.10
  19. Paul A Scheet · 1 shared paper, 2019 · strength 0.07
  20. Subrata Sen · 1 shared paper, 2019 · strength 0.07
  21. Michael P. Kim · 1 shared paper, 2019 · strength 0.07
  22. Aatur Dilip Singhi · 1 shared paper, 2019 · strength 0.07
  23. Ching-Wei David Tzeng · 1 shared paper, 2019 · strength 0.07
  24. Joseph M. Herman · 1 shared paper, 2019 · strength 0.07
  25. Eugene Jon Koay · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.